Tiletamine,Zolazepam,Butorphanol,Dexmedetomidine
18 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
18
Total Reports
1
Deaths Reported
560.0%
Death Rate
Active Ingredients
Tiletamine,Zolazepam,Butorphanol,Dexmedetomidine
Administration Routes
UnknownIntramuscular
Species Affected
Cat 12
Dog 6
Most Affected Breeds
Domestic Shorthair 8
Retriever - Labrador 3
Cat (unknown) 2
Dog (unknown) 1
Dalmatian 1
Dachshund (unspecified) 1
Domestic Mediumhair 1
Siamese 1
Most Reported Reactions
Behavioural disorder NOS 7
Not eating 4
Dysphoria 3
Wobbliness 3
Fever 3
Vomiting 2
Hyperactivity 2
Not himself/herself 2
Lethargy (see also Central nervous system depression in Neurological) 2
Unwell 2
Lateral recumbency 2
Tooth loss 2
Outcome Breakdown
Recovered/Normal
11 (61.1%)
Ongoing
5 (27.8%)
Outcome Unknown
1 (5.6%)
Died
1 (5.6%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.